— Know what they know.
Not Investment Advice

NSTM OTC

NovelStem International Corp.
1W: -2.5% 1M: +5.3% 3M: +0.0% YTD: +0.0% 1Y: -66.7% 3Y: -95.0% 5Y: -96.2%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 37 · $493325 mcap · 14M float · 0.146% daily turnover · Short 53% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.5M
52W Range0.0062-0.04
Volume50,000
Avg Volume20,685
Beta2.47
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJan H. Loeb
Employees2
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1993-11-12
2255 Glades Road
Boca Raton, FL 33431
US
410 654 3315
About NovelStem International Corp.

NovelStem International Corp. concentrates its efforts on pioneering and introducing diagnostic solutions for cancer treatment, specifically with the goal of mitigating chemotherapy resistance. The company, which commenced operations in 1993, was previously recognized as Hollywood Media Corp. before adopting its current name in September of 2018. Its corporate headquarters are situated in Boca Raton, Florida.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms